CUBIST PHARMACEUTICALS INC Revenue
CUBIST PHARMACEUTICALS INC reported Revenue of $309.15 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2014-11-07
- CUBIST PHARMACEUTICALS INC revenues for the quarter ending 2014-09-30 was $309.15M, a 16.23% increase year-over-year.
- CUBIST PHARMACEUTICALS INC revenues for the quarter ending 2014-06-30 was $294.40M, a 13.76% increase year-over-year.
- CUBIST PHARMACEUTICALS INC revenues for the quarter ending 2014-03-31 was $261.23M, a 13.61% increase year-over-year.
- CUBIST PHARMACEUTICALS INC revenues for the quarter ending 2013-12-31 was $299.74M, a 21.89% increase year-over-year.
- CUBIST PHARMACEUTICALS INC revenues for fiscal 2013 was $1.05B, a 13.83% increase from fiscal 2012.
- CUBIST PHARMACEUTICALS INC revenues for fiscal 2012 was $926.36M, a 22.86% increase from fiscal 2011.
- CUBIST PHARMACEUTICALS INC revenues for fiscal 2011 was $753.97M, a 18.46% increase from fiscal 2010.
- CUBIST PHARMACEUTICALS INC revenues for fiscal 2010 was $636.46M, a 13.22% increase from fiscal 2009.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2014-09-30 | $309.15M 10-Q · filed 2014-11-07 | $603.55M derived: sum of 2 quarters · filed 2014-11-07 | $864.79M 10-Q · filed 2014-11-07 | $1.16B derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | $294.40M 10-Q · filed 2014-08-11 | $555.63M 10-Q · filed 2014-08-11 | $855.37M derived: sum of 3 quarters · filed 2014-08-11 | $1.12B derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-03-31 | $261.23M 10-Q · filed 2014-05-02 | $560.97M derived: sum of 2 quarters · filed 2014-05-02 | $826.97M derived: sum of 3 quarters · filed 2014-11-07 | $1.09B derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-12-31 | $299.74M 10-K · filed 2014-02-25 | $565.73M derived: sum of 2 quarters · filed 2014-11-07 | $824.51M derived: sum of 3 quarters · filed 2014-11-07 | $1.05B 10-K · filed 2014-02-25 |
| 2013-09-30 | $265.99M 10-Q · filed 2014-11-07 | $524.77M derived: sum of 2 quarters · filed 2014-11-07 | $754.70M 10-Q · filed 2014-11-07 | $1.00B derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $258.78M 10-Q · filed 2014-08-11 | $488.71M 10-Q · filed 2014-08-11 | $734.63M derived: sum of 3 quarters · filed 2014-08-11 | $972.81M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $229.93M 10-Q · filed 2014-05-02 | $475.85M derived: sum of 2 quarters · filed 2014-05-02 | $714.03M derived: sum of 3 quarters · filed 2014-05-02 | $944.60M derived: sum of 4 quarters · filed 2014-05-02 |
| 2012-12-31 | $245.92M 10-K · filed 2014-02-25 | $484.10M derived: sum of 2 quarters · filed 2014-02-25 | $714.67M derived: sum of 3 quarters · filed 2014-02-25 | $926.36M 10-K · filed 2014-02-25 |
| 2012-09-30 | $238.18M 10-K · filed 2014-02-25 | $468.75M derived: sum of 2 quarters · filed 2014-02-25 | $680.44M 10-Q · filed 2013-11-12 | $893.35M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $230.57M 10-K · filed 2014-02-25 | $442.26M 10-Q · filed 2013-08-06 | $655.16M derived: sum of 3 quarters · filed 2014-02-25 | $856.86M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $211.69M 10-K · filed 2014-02-25 | $424.60M derived: sum of 2 quarters · filed 2014-02-25 | $626.29M derived: sum of 3 quarters · filed 2014-02-25 | $803.13M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $212.91M 10-K · filed 2013-02-27 | $414.60M derived: sum of 2 quarters · filed 2013-02-27 | $591.44M derived: sum of 3 quarters · filed 2013-02-27 | $753.97M 10-K · filed 2014-02-25 |
| 2011-09-30 | $201.70M 10-K · filed 2013-02-27 | $378.54M derived: sum of 2 quarters · filed 2013-02-27 | $541.07M 10-Q · filed 2012-11-05 | $702.87M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $176.84M 10-K · filed 2013-02-27 | $339.37M 10-Q · filed 2012-08-07 | $501.17M derived: sum of 3 quarters · filed 2013-02-27 | $663.23M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $162.53M 10-K · filed 2013-02-27 | $324.34M derived: sum of 2 quarters · filed 2013-02-27 | $486.39M derived: sum of 3 quarters · filed 2013-02-27 | $654.92M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $161.81M 10-K · filed 2012-02-27 | $323.86M derived: sum of 2 quarters · filed 2012-02-27 | $492.39M derived: sum of 3 quarters · filed 2012-02-27 | $636.46M 10-K · filed 2013-02-27 |
| 2010-09-30 | $162.05M 10-K · filed 2012-02-27 | $330.59M derived: sum of 2 quarters · filed 2012-02-27 | $474.65M 10-Q · filed 2011-11-02 | $641.37M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $168.54M 10-K · filed 2012-02-27 | $312.60M 10-Q · filed 2011-07-29 | $479.32M derived: sum of 3 quarters · filed 2012-02-27 | $622.86M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $144.06M 10-K · filed 2012-02-27 | $310.79M derived: sum of 2 quarters · filed 2012-02-27 | $454.32M derived: sum of 3 quarters · filed 2012-02-27 | $585.10M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | $166.72M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $310.25M derived: sum of 2 quarters · filed 2012-02-27 | $441.03M derived: sum of 3 quarters · filed 2012-02-27 | $562.14M 10-K · filed 2012-02-27 |
| 2009-09-30 | $143.53M 10-Q · filed 2010-10-29 | $274.31M derived: sum of 2 quarters · filed 2010-10-29 | $395.42M 10-Q · filed 2010-10-29 | |
| 2009-06-30 | $130.78M 10-Q · filed 2010-07-30 | $251.89M 10-Q · filed 2010-07-30 | ||
| 2008-12-31 | $433.64M 10-K · filed 2011-02-23 |